-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroDex CEO Presents Blood-Based Biomarker Research at Arthur L. Haas Endowed Lecture

PUBT·11/10/2026 19:26:42
Listen to the news
NeuroDex CEO Presents Blood-Based Biomarker Research at Arthur L. Haas Endowed Lecture
  • NeuroDex CEO Erez Eitan will deliver the sixth Arthur L. Haas Endowed Lecture at LSU Health New Orleans on Nov. 11, 2026.
  • His presentation will cover blood-based biomarker research in neurodegenerative diseases, focusing on potential applications in disease monitoring, treatment evaluation and clinical trials.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeuroDex Inc. published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.